![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1532525
ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ¼¼°è ¿¹Ãø(2024-2032³â)Disposable Ureteroscope Market - By Product (Flexible Ureteroscope, Rigid Ureteroscope), By Application (Urolithiasis, Urethral Stricture, Kidney Cancer), By End-use (Hospitals, Ambulatory Surgical Centers) & Global Forecast (2024 - 2032) |
ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå ±Ô¸ð´Â 2024-2032³â CAGR 17%·Î È®´ëÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¾ö°ÝÇÑ ±ÔÁ¦ °¨¿° °ü¸® ±âÁØÀÌ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
ÀÏȸ¿ë ¿ä°ü°æÀº ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÃÖ¼ÒÈÇÏ°í »ç¿ë °£ Àçó¸®ÀÇ Çʿ伺À» Á¦°ÅÇÏ¿© ¼ö¼ú °úÁ¤À» °£¼ÒÈÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
º´¿ø ¹× Ŭ¸®´ÐÀº ÁøÈÇϴ ǥÁØÀ» ÃæÁ·Çϰí ȯÀÚ ¾ÈÀüÀ» °ÈÇϱâ À§ÇØ ÀÌ·¯ÇÑ Àåºñ¸¦ äÅÃÇϰí ÀÖ½À´Ï´Ù. °¨¿° À§ÇèÀ» ÁÙÀÌ°í ¼º´ÉÀ» Çâ»ó½Ã۱â À§ÇØ Ã·´Ü ¼ÒÀç¿Í µðÀÚÀÎ Çõ½ÅÀ» äÅÃÇÏ´Â »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Ç° ¼ö¿ä´Â ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 4¿ù ¿Ã¸²Çª½º´Â °¨¿° °ü¸® ¹®Á¦¸¦ ÇØ°áÇÏ´Â µ¿½Ã¿¡ ½Ã¼ú È¿À²À» ³ôÀÌ´Â ÃÖÃÊÀÇ ÀÏȸ¿ë Ç÷º¼ºí ¿ä°ü°æÀÎ RenaFlex(TM)ÀÇ FDA ½ÂÀÎÀ» ¹ßÇ¥Çß½À´Ï´Ù.
¿ëµµº°·Î´Â ½ÅÀå¾Ï ºÐ¾ßÀÇ ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå °¡Ä¡´Â 2024-2032³â »ó´çÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ÀÇ·á ÀýÂ÷¿¡ ÅëÇյǾî Á¤È®µµ¸¦ ³ôÀ̰í ÀÏȸ¿ë ¼³°è·Î °¨¿° À§ÇèÀ» ÃÖ¼ÒÈÇϱâ À§ÇØ ÀÇ·á ÀýÂ÷¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ¿Ü°úÀÇ»çµéÀº ÀÏȸ¿ë ¿ä°ü°æÀ» »ç¿ëÇÏ¿© Àç»ç¿ë °¡´ÉÇÑ ³»½Ã°æÀÇ Àç󸮿¡ µû¸¥ º¹À⼺À» ÇÇÇÏ¸é¼ Á¾¾çÀ» º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀ¸·Î Á¢±ÙÇϰí Ä¡·áÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ½Å¼ÓÇÑ °³¹ßÀº ½ÅÀå¾Ï Ä¡·á¿¡ µµ¿òÀÌ µÇ¾î ½Ã¼ú ½Ã°£À» ´ÜÃàÇϰí ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù.
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)(ASCs) ÃÖÁ¾ »ç¿ë ºÎ¹®ÀÇ ÀÏȸ¿ë ¿ä°ü°æ »ê¾÷Àº 2032³â±îÁö »ó´çÇÑ CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ½Ã¼ú È¿À²¼º°ú ȯÀÚ ¾ÈÀüÀ» ³ôÀ̱â À§ÇØ ÀÌ·¯ÇÑ È¯°æ¿¡¼ ÀÏȸ¿ë ¿ä°ü°æ äÅÃÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌµé ¼¾ÅÍ´Â ¼ö¼ú °úÁ¤À» °£¼ÒÈÇÏ°í ±³Â÷ ¿À¿°ÀÇ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ³»½Ã°æ ±â¼úÀÇ ÃֽйßÀüÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀ¸·Î ASC´Â ¾÷¹« ¿öÅ©Ç÷ο츦 ÃÖÀûÈÇϰí Àü¹ÝÀûÀΠȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ÀÏȸ¿ë Àåºñ¸¦ ´õ ±¤¹üÀ§ÇÏ°Ô Ã¤ÅÃÇÏ´Â ¹æÇâÀ¸·Î ³ª¾Æ°¡°í ÀÖ½À´Ï´Ù.
Áö¿ªº°·Î À¯·´ÀÇ ÀÏȸ¿ë ¿ä°ü°æ ½ÃÀå ±Ô¸ð´Â ÀÇ·á ¼ºñ½º È®´ë¿Í ºñ´¢±â°ú ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2024-2032³â Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÇ·á ±â°üÀº È¿°úÀûÀ̰í À§»ýÀûÀÎ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÏȸ¿ë ¿ä°ü°æÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÏȸ¿ë Àåºñ´Â ºñ´¢±â°ú ÇコÄɾ À§ÇÑ º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÏ¿© ÀÌ ºÐ¾ß¿¡¼ ´õ ³ªÀº ȯÀÚ °á°ú¿Í °£¼ÒÈµÈ ½Ã¼ú °üÇàÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.
Disposable Ureteroscope Market size is projected to expand at 17% CAGR from 2024 to 2032, led by stringent regulatory infection control standards. Disposable ureteroscopes are designed to minimize the risk of cross-contamination and streamline the surgical process by eliminating the need for reprocessing between uses.
Hospitals and clinics are adopting these devices to meet the evolving standards and enhance patient safety. Rising incorporation of advanced materials and design innovations to reduce infection risks and improve performance will further add to the product demand. For instance, in April 2024, Olympus announced FDA clearance for RenaFlex(TM), the first single-use flexible ureteroscope that addresses infection control concerns while enhancing procedural efficiency.
The overall market is segregated into product, application, end-use, and region.
Based on application, the disposable ureteroscope market value from the kidney cancer segment is estimated to rise at significant rate from 2024 to 2032. These devices are integrated into medical procedures to enhance precision and minimize infection risks due to their single-use designs. Surgeons are utilizing disposable ureteroscopes to access and treat tumors with greater safety and efficiency whilst avoiding the complexities associated with reprocessing reusable scopes. In addition, rapid developments are helping in kidney cancer treatment for reducing procedure times and enhancing patient outcomes.
Disposable ureteroscope industry from the ambulatory surgical centers (ASCs) end-use segment is anticipated to expand at substantial CAGR up to 2032. This is owing to the increasing adoption of disposable ureteroscopes in these settings to enhance procedural efficiency and patient safety. These centers are incorporating the latest advancements in endoscopic technology to streamline surgical processes and reduce the risk of cross-contamination. This evolution is further driving ASCs towards adopting single-use devices more widely for optimizing operational workflows and improving overall patient outcomes.
Regionally, the Europe disposable ureteroscope market size is projected to depict immense growth between 2024 and 2032, on account of healthcare expansion and the rising prevalence of urological conditions. Healthcare facilities are integrating disposable ureteroscopes to address the growing demand for effective and hygienic diagnostic tools. These single-use devices are providing safer and more efficient solutions for managing urological health and supporting better patient outcomes and streamlined procedural practices in the region.